Pancreatic Cancer Research

ResearcherKyushu UniversityNo recent work listed

Mai Yamashita

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 2

  1. PPAR/PDK4 pathway is involved in the anticancer effects of cGMP in pancreatic cancer. Co-author DOI 10.1016/j.bbrc.2023.06.043↗
  2. FOXO3 is essential for CD44 expression in pancreatic cancer cells. Co-author DOI 10.1038/onc.2016.426↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Motofumi Kumazoe · 2 shared papers, 2017–2023 · strength 0.26
  2. Hirofumi Tachibana · 2 shared papers, 2017–2023 · strength 0.26
  3. Yoshinori Fujimura · 1 shared paper, 2023 · strength 0.20
  4. Masaharu Murata · 1 shared paper, 2017 · strength 0.06
  5. Shuntaro Tsukamoto · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.